Evidence map›Paper›PMID 15489898›Full record

ArticleOncogene2004

Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis.

Lin Wei, Yu Yang, Xin Zhang, Qiang Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 93 citations in OpenAlex.

  1. Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2010
    Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Role of Pyk2 in Human Cancers.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cbl-b accelerates trypsin-induced cell detachment through ubiquitination and degradation of proline-rich tyrosine kinase 2.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Lin WeiDepartment of Medicine, Pulmonary Center, Boston, MA 02118, USA.
Yu Yang
Xin Zhang
Qiang Yu
Boston Medical Center · USBoston University · USPulmonary Associates · USUniversity Medical Center · US

Funding

FUNCTION OF P130 CAS IN CELL SURVIVALR01GM059678 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI YU, QIANG · 1999 to 2002
$791k
NIGMS NIH HHS R01 GM59678
6 · The paper itself

Abstract

Src plays an important role in cell proliferation, differentiation, adhesion, and migration. Altered Src activity has been strongly implicated in the development, growth, progression, and metastasis of human cancers. We have analysed the change and regulation of Src upon cell detachment in anoikis-resistant human lung adenocarcinoma cells and compared with that of relatively normal and anoikis-sensitive epithelial cells. We found that Src activity was increased in the anoikis-resistant lung tumor cells when they were detached and cultured in suspension. The detachment-induced Src activation in the tumor cells compensates for the loss of cell survival signals caused by disruption of cell--matrix interactions and contributes to anoikis resistance of the tumor cells. Pyk2, rather than PI 3K/Akt or Erk, appears to be the key downstream effecter of Src in mediating the cell survival signals. The increased Src activity is mainly due to the phosphorylation of Tyr-419, rather than the dephosphorylation of Tyr-530 of Src protein. PDGFR, not FAK or EGFR, appears to be the upstream protein tyrosine kinase responsible for the detachment-induced Src activation in the lung tumor cells. The increased Src activity upon cell detachment may contribute to the metastasis potential of malignant tumors.

Indexed as

AnoikisAdenocarcinomaAnimalsCell LineDogsHumansLung NeoplasmsMitogen-Activated Protein KinasesOncogene Protein pp60(v-src)Phosphatidylinositol 3-KinasesReceptors, Platelet-Derived Growth FactorMitogen-Activated Protein KinasesOncogene Protein pp60(v-src)Phosphatidylinositol 3-KinasesReceptors, Platelet-Derived Growth Factor

Identifiers

PMID15489898
OpenAlexW2022650754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.